Team

Founders and Management

Diorasis in Greek means the power to perceive things in the future and the ability to see things that others cannot. We believe our pioneering gene therapy can open new horizons in ophthalmology and become a “functional cure” for glaucoma patients.

We have the winning combination of groundbreaking science, brilliant researchers and clinicians, and industry leaders. We are passionate, talented, collaborative, purpose-driven, and we’re growing rapidly. We need people like you.

Are you inspired to improve patients’ lives? Are you curious, and do you enjoy teamwork? Do you thrive by making a direct impact? Do you want to shape your own future? Then, Diorasis Therapeutics is a great fit.

Mark N. Milton, PhD

Gene Therapies and Biologics

John Danias, MD, PHD

Clinician Ccientist

Kali Stasi, MD, PhD

renowned expert

Terete Borrás

molecular biologist

Bodil Willumsen, PhD

gene therapy manufacturing

Remis Bistras

CEO of Diorasis Therapeutics

Kuldev Singh

Member Designation

Dirk Sauer

Member Designation

Scientific Advisors and Consultants

Name

Member Designation

Name

Member Designation

Name

Member Designation

Name

Member Designation

Name

Member Designation

Name

Member Designation

Name

Member Designation

Name

Member Designation

Name

Member Designation

Name

Member Designation

Name

Member Designation

Name

Member Designation